Pharmafile Logo

DJM Digital opens New York office

Will work alongside Creston Health’s US companies

DJM Digital (DJM) is officially taking its expertise to the US with the opening of a New York office.

The agency, which provides consultancy, strategic and creative solutions predominantly to the healthcare/pharmaceutical industry, will work with Creston Health’s US companies to apply its expertise in the US market.

DJM managing director, Dominic Marchant, said: “The US opportunity is really exciting because it’s a different regulatory set up, so there’s greater scope to do possibly more adventurous things. London is still perceived as a hot house of digital creativity and we will definitely be keen to demonstrate that when we talk to companies across the Atlantic. We bring something that isn’t already available so we’re fulfilling a real need for them.

While recruiting is underway for someone to head up the US DJM Digital business, members of the London team will be seconded to the New York office to help up-skill existing Creston Health staff.

While there are a lot of agencies that specialise in digital and a lot of integrated agencies that also bring a digital offering, Marchant believes none of them do what he does at DJM.

“Digital is undoubtedly one of the most cost-effective ways of communicating messages in a compelling way to a large audience,” said Marchant. “But it becomes really exciting when it is part of an integrated campaign because digital on its own doesn’t really mean much until you bring it in to the bigger picture.

“It’s exciting to be at the forefront of digital technology and produce clever solutions, which effectively deliver client messages to their target audiences.”

Creston took a majority share in DJM Digital in November 2012 as part of its aim to grow its health division. Creston purchased 75 per cent of DJM Digital shares for an initial sum of £1.2m. The remaining 25 per cent of shares can be bought by Creston for £2.4m from 2018. DJM reported revenues of £0.6m in 2012 and a pre-tax profit of £0.2m.

Unaudited results for the year ended March 31 2013 showed that Creston’s digital and online revenue increased by 16 per cent which represented 48 per cent of the Group’s revenue.

The group’s other companies operating in the health and pharmaceutical market include Alembic Health Communications, Cooney Waters, The Corkery Group, DJM Digital Solutions, Grapevine, PAN, Red Door Communications and Rock Medical Communications.

Article by Sylvie Wootton
13th June 2013
From: Marketing
Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links